Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD

Respirology

Volumn 14, Issue 2, 2009, Pages 260-263

  Kim, Woo J ^b   Sheen, Seung S ^c   Kim, Tae Hyung ^d   Huh, Jin W ^e   Lee, Ji Hyun ^f   Kim, Eun Kyung ^f   Lee, Jin H ^g   Lee, Sang Min ^h   Lee, Sangyeub ⁱ   Lim, Seong Y ^j   Shin, Tae R ^k   Yoon, Ho I ^l   Oh, Yeon Mok ^a   Lee, Sang D ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Hanyang University Guri Hospital   (South Korea)

^e Inje University   (South Korea)

^f CHA University   (South Korea)

^g Mokdong Hospital   (South Korea)

^h Seoul National University Hospital   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Sungkyunkwan University School of Medicine   (South Korea)

^k Hallym University College of Medicine   (South Korea)

^l Seoul National University Bundang Hospital   (South Korea)

more..

Author keywords

COPD; Corticosteroid; CRHR1; Polymorphism

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FLUTICASONE PROPIONATE; SALMETEROL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HETEROZYGOSITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 61349181840     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01425.x     Document Type: Article

References (17)

1. Kim DS, Kim YS, Jung K-S, Chang JH, Lim C-M et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am. J. Respir. Crit. Care Med. 2005 172 : 842 7.
2. Shin C, Lee S, Abbott RD, Kim JH, Lee SY et al. Respiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: The Korean Health and Genome Study. Chest 2004 126 : 1234 40.
3. American Thoracic Society/European Respiratory Society Task Force. Standards for the Diagnosis and Management of Patients with COPD [Internet]. Version 1.2. American Thoracic Society, New York, 2004 [updated 8 September 2005]. [Accessed 15 March 2008.] Available from URL: http://www.thoracic.org/go/ copd.
4. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007 176 : 532 55.
5. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007 356 : 775 89.
6. Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007 175 : 144 9.
7. Yang IA, Ng T, Molenaar P, Fong KM. Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design. Clin. Exp. Pharmacol. Physiol. 2007 34 : 1029 36.
8. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum. Mol. Genet. 2004 13 : 1353 9.
9. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann. Intern. Med. 2003 139 : 359 70.
10. Bourbeau J, Christodoulopoulos P, Maltais F, Yamauchi Y, Olivenstein R et al. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax 2007 62 : 938 43.
11. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C et al. On the replication of genetic associations: timing can be everything! Am. J. Hum. Genet. 2008 82 : 849 58.
12. Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res. 2005 15 : 1592 3.
13. Lin P-I, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 2007 80 : 531 8.
14. Liu Z, Zhu F, Wang G, Xiao Z, Wang H et al. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci. Lett. 2006 404 : 358 62.
15. Liu Z, Zhu F, Wang G, Xiao Z, Tang J et al. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders. Neurosci. Lett. 2007 414 : 155 8.
16. Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G et al. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol. Psychiatry 2008 63 : 146 51.
17. Tantisira KG, Small KM, Litonjua AA, Weiss ST, Liggett SB. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between β-agonist and corticosteroid pathways. Hum. Mol. Genet. 2005 14 : 1671 7.